⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6130343 | 1.00 | — | — | |
| SCHEMBL22788043 | 1.00 | — | — | |
| SCHEMBL138796 | 1.00 | — | — | |
| SCHEMBL6130344 | 1.00 | — | — | |
| SCHEMBL5665282 | 1.00 | — | — | |
| SCHEMBL17490492 | 1.00 | — | — | |
| SCHEMBL6589274 | 0.95 | CYP1A2 (0.37) | — | |
| SCHEMBL6587355 | 0.92 | CYP1A2 (0.41) | — | |
| SCHEMBL29065440 | 0.85 | CYP1A2 (0.39) | — | |
| SCHEMBL21088455 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119581671-A | Nonaqueous electrolyte and lithium ion battery | 深圳新宙邦科技股份有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-119560637-A | Lithium ion battery | 深圳新宙邦科技股份有限公司 | 2025-03-04 | — | — | CN | claimed |
| CN-119542543-A | Nonaqueous electrolyte and secondary battery | 深圳新宙邦科技股份有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-114628773-B | Lithium ion battery | 深圳新宙邦科技股份有限公司 | 2025-01-14 | — | — | CN | claimed |
| CN-114628773-A | Lithium ion battery | 深圳新宙邦科技股份有限公司 | 2022-06-14 | — | — | CN | claimed |
| CN-119581671-A | Nonaqueous electrolyte and lithium ion battery | 深圳新宙邦科技股份有限公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-119560636-A | Nonaqueous electrolyte and secondary battery | 深圳新宙邦科技股份有限公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-119560637-A | Lithium ion battery | 深圳新宙邦科技股份有限公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-119542543-A | Nonaqueous electrolyte and secondary battery | 深圳新宙邦科技股份有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-119542544-A | Nonaqueous electrolyte and secondary battery | 深圳新宙邦科技股份有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-114628773-B | Lithium ion battery | 深圳新宙邦科技股份有限公司 | 2025-01-14 | — | — | CN | disclosed |
| CN-114628773-A | Lithium ion battery | 深圳新宙邦科技股份有限公司 | 2022-06-14 | — | — | CN | disclosed |
| EP-1461041-A4 | PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES | PHARMASSET LTD (BB) | 2006-03-29 | — | — | EP | disclosed |
| US-6908924-B2 | For therapy and prophylaxis of human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections, in human patients or other animal hosts | PHARMASSET, INC. (US) | 2005-06-21 | — | — | US | disclosed |
| US-20040214844-A1 | N4-acylcytosine nucleosides for treatment of viral infections | GILEAD PHARMASSET LLC | 2004-10-28 | — | — | US | disclosed |
| EP-1461041-A2 | PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES | Pharmasset Ltd. (BB) | 2004-09-29 | — | — | EP | disclosed |
| US-20030176319-A1 | For therapy and prophylaxis of human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections, in human patients or other animal hosts | GILEAD PHARMASSET LLC | 2003-09-18 | — | — | US | disclosed |
| WO-2003051298-A2 | PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES | PHARMASSET LTD. (BB) | 2003-06-26 | — | — | WO | disclosed |
| US-6500219-B1 | COMBINING SULFIDE-CONTAINING DIESEL FUEL HAVING CETANE INDEX OF GREATER THAN 50.0 WITH AQUEOUS FLUID AND HYDROPEROXIDE AND ALIPHATIC C15-C20 HYDROCARBON, USING ULTRASOUND TO CAUSE OXIDATION OF SULFIDES | SULPHCO, INC. | 2002-12-31 | — | — | US | disclosed |
| WO-1998000478-A1 | DESULFURIZATION AND HYDROCARBON QUALITY ENHANCEMENT PROCESS | INTERGLOBAL DESULFURIZATION SYSTEMS, INC. (US) | 1998-01-08 | — | — | WO | disclosed |